CONCLUSION:
SCO of the ribs is exceptional and should be kept in mind in the
management of ribs’ tumors. Early diagnosis is important for
better-improved prognosis. The integration of clinical, radiologic,
pathologic, and ancillary test results, including immunohistochemical
and molecular results is necessary to establish the right diagnosis.
Surgical resection is the only curative treatment and it should be as
complete as possible. Adjuvant chemotherapy may improve survival despite
the poor prognosis of this aggressive type of bone malignant tumors.
REFERENCES:
- WHO Classification of Tumors Editorial Board eds. World Health
Organization classification of soft tissue and bone tumors. 5th
edition. Lyon: IARC Press, 2020.
- Martin SE, Dwyer A, Kissane JM, Costa J. Small-cell osteosarcoma.
Cancer 1982; 50: 990-6.
- Devaney K, Vinh TN, Sweet DE. Small cell osteosarcoma of bone: an
immunohistochemical study with differential diagnostic considerations.
Hum Pathol 1993; 24: 1211-25.
- Göktürk
Fındık, Ersin Günay, Yetkin Ağaçkıran, Koray Aydoğdu, Ertan
Aydın, Sadi Kaya. Small cell osteosarcoma of rib: diagnosis and
treatment of the rare case. Tuberk Toraks 2012; 60: 172-5.
- S
H
Park, I
Kim. Small cell osteogenic sarcoma of the ribs: cytological,
immunohistochemical, and ultrastructural study with literature review.
Ultrastruct Pathol 1999; 23: 133-40.
- Lushiku HB, Gebhart M. Osteosarcoma of the proximal fibula: report of
3 cases. Acta Chir Belg 1997; 97: 260-3.
- Dickersin GR, Rosenberg AE. The ultrastructure of small-cell
osteosarcoma, with a review of the light microscopy and differential
diagnosis. Hum Pathol 1991; 22: 267-75.
- Glasser DB, Lane JM, Huvos AG, Marcove RC, Rosen G. Survival,
prognosis, and therapeutic response in osteogenic sarcoma. The
Memorial Hospital experience. Cancer 1992; 69: 698-708.
ANNEXES: